Dr. Justin Moser, MD
Claim this profileHonorHealth Research Institute
Studies Solid Tumors
Studies Melanoma
16 reported clinical trials
32 drugs studied
Area of expertise
1Solid Tumors
Stage IV
Stage III
2Melanoma
Stage IV
Stage III
HLA-A positive
Affiliated Hospitals
Clinical Trials Justin Moser, MD is currently running
ODC-IL2
for Cancer
This is a first-in-human, Phase I, multicenter, open-label, dose escalation study with dose expansion to evaluate the safety and antitumor activity of ODC-IL2 in patients with advanced or metastatic solid tumors. ODC-IL2 is a conditionally activated IL-2 prodrug and will be administered as a single agent via intravenous infusion on Days 1 and 15 of a 28-day cycle. Up to approximately 50 patients will be enrolled in this study.
Recruiting1 award Phase 14 criteria
SPX-303
for Solid Tumors
Part 1 of this study is an open-label, dose-escalation, and safety expansion study of an anti-LILRB2 / anti-PD-L1 bispecific antibody SPX- 303 in patients with solid tumors. Part 2 of this study is an indication-specific dose expansion study of SPX-303.
Recruiting1 award Phase 1
More about Justin Moser, MD
Clinical Trial Related3 years of experience running clinical trials · Led 16 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Justin Moser, MD has experience with
- Nivolumab
- Ipilimumab
- Novocure Optune
- Autologous T Cell Therapy
- TSC-204-A0201
- TSC-200-A0201
Breakdown of trials Justin Moser, MD has run
Solid Tumors
Melanoma
Lung Cancer
Squamous Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Justin Moser, MD specialize in?
Justin Moser, MD focuses on Solid Tumors and Melanoma. In particular, much of their work with Solid Tumors has involved Stage IV patients, or patients who are Stage III.
Is Justin Moser, MD currently recruiting for clinical trials?
Yes, Justin Moser, MD is currently recruiting for 8 clinical trials in Scottsdale Arizona. If you're interested in participating, you should apply.
Are there any treatments that Justin Moser, MD has studied deeply?
Yes, Justin Moser, MD has studied treatments such as Nivolumab, Ipilimumab, Novocure Optune.
What is the best way to schedule an appointment with Justin Moser, MD?
Apply for one of the trials that Justin Moser, MD is conducting.
What is the office address of Justin Moser, MD?
The office of Justin Moser, MD is located at: HonorHealth Research Institute, Scottsdale, Arizona 85258 United States. This is the address for their practice at the HonorHealth Research Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.